ClinicalTrials.Veeva

Menu

Effect of PTH(1-34) Treatment on Fracture Healing in Vivo

G

Glostrup University Hospital, Copenhagen

Status and phase

Withdrawn
Phase 2

Conditions

Shoulder Fractures
Trochanteric Fractures

Treatments

Drug: rhPTH(1-34)

Study type

Interventional

Funder types

Other

Identifiers

NCT00741182
EudraCT 2008-000094-37
FAO_06_011

Details and patient eligibility

About

The purpose of the study is to investigate, whether PTH(1-34) is able to promote fracture healing in postmenopausal women with fractures of the hip or shoulder.

Sex

Female

Ages

50 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute new osteoporotic trochanteric or collum chirurgicum fracture
  • Postmenopause

Exclusion criteria

  • Calcium metabolic disease other than osteoporosis
  • Diseases known to affect calcium homeostasis
  • Dementia
  • Hypersensitivity to drug or other components of medication
  • pre-existing hypercalcemia
  • Decreased kidney function
  • Increased alkaline phosphatase
  • Prior external radiation therapy or brachytherapy of the skeleton
  • Skeletal malignancies or bone metastases
  • Alcohol and/or drug abuse
  • Systemic treatment with corticosteroids within the last four weeks
  • Non-cooperating patients
  • Patients who do not speak and understand the danish language

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 4 patient groups

Femur PTH(1-34)
Experimental group
Description:
24 participants with trochanteric fractures will be assigned to Forsteo (PTH(1-34)) treatment
Treatment:
Drug: rhPTH(1-34)
Femur Control
No Intervention group
Description:
24 participants with trochanteric fractures will be assigned to "no treatment"
Humerus PTH(1-34)
Experimental group
Description:
24 participants with collum chirurgicum fracture will be assigned to Forsteo (PTH(1-34)) treatment
Treatment:
Drug: rhPTH(1-34)
Humerus Control
No Intervention group
Description:
24 participants with collum chirurgicum fracture will be assigned to "no treatment".

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems